NEPH
Nephros, Inc. NASDAQ Listed Sep 21, 2004$4.38
+4.04%
vs $4.21
Mkt Cap $48.0M
52w Low $2.78
53.2% of range
52w High $5.79
50d MA $3.51
200d MA $3.98
P/E (TTM)
62.0x
EV/EBITDA
49.8x
P/B
4.6x
Debt/Equity
0.1x
ROE
14.3%
P/FCF
29.2x
RSI (14)
67.70
ATR (14)
$0.30
Beta
1.56
50d MA
$3.51
200d MA
$3.98
Avg Volume
13.6K
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
380 Lackawanna Place · South Orange, NJ 07079 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | AMC | 0.01 | 0.01 | +0.0% | 3.59 | +5.8% | +17.3% | — | — | — | — | — |
| May 7, 2026 | AMC | 0.01 | 0.01 | +0.0% | 3.23 | -4.3% | +9.0% | -16.2% | +2.0% | +17.9% | -5.9% | — |
| Mar 12, 2026 | AMC | 0.01 | 0.01 | +0.0% | 3.80 | -4.2% | -7.9% | -16.6% | +2.7% | +2.0% | -3.6% | — |
| Nov 6, 2025 | AMC | -0.02 | 0.03 | +250.0% | 5.20 | +1.9% | -11.5% | -6.7% | +0.9% | +5.3% | -3.1% | — |
| Aug 7, 2025 | AMC | -0.03 | 0.02 | +180.0% | 2.89 | +17.6% | +34.9% | +15.1% | -5.1% | -3.3% | -2.9% | — |
| May 15, 2025 | AMC | 0.01 | 0.05 | +400.0% | 2.14 | -1.4% | +0.9% | -0.5% | +7.0% | -1.7% | +16.4% | — |
| May 9, 2025 | AMC | -0.01 | 0.05 | +1100.0% | 1.90 | +6.3% | +8.9% | +4.8% | -3.7% | +2.4% | +0.9% | — |
| Mar 24, 2025 | AMC | -0.01 | 0.03 | +400.0% | 1.52 | +2.6% | +1.3% | +3.9% | +4.4% | +0.0% | +3.0% | — |
| Mar 7, 2025 | AMC | -0.01 | 0.03 | +400.0% | 1.65 | +2.4% | -1.8% | +0.0% | +2.5% | -2.4% | +0.6% | — |
| Nov 7, 2024 | AMC | 0.01 | 0.02 | +199.4% | 1.55 | +5.2% | +3.9% | +0.0% | +1.9% | -0.6% | -3.1% | — |
| Aug 8, 2024 | AMC | -0.01 | -0.03 | -100.0% | 2.13 | -6.1% | -8.0% | -2.0% | -1.6% | -0.5% | -0.5% | — |
| May 9, 2024 | AMC | -0.01 | -0.02 | -50.3% | 2.22 | -2.3% | -5.4% | +0.0% | +1.4% | -3.8% | +10.7% | — |
| Mar 7, 2024 | AMC | -0.03 | -0.06 | -140.0% | 3.02 | -3.0% | -10.6% | -9.6% | -4.9% | -2.6% | -4.4% | — |
| Nov 8, 2023 | AMC | -0.06 | -0.02 | +66.7% | 2.01 | -8.2% | -2.6% | +0.3% | +6.1% | +0.5% | -1.0% | — |
| Aug 9, 2023 | AMC | -0.05 | -0.04 | +20.0% | 1.40 | +5.7% | +7.9% | -0.7% | +2.0% | -1.3% | +5.3% | — |
| May 10, 2023 | AMC | -0.02 | -0.03 | -50.0% | 1.46 | +6.2% | -0.7% | -2.1% | -12.0% | -4.0% | -0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 | Northland Capital | Initiates | Market Perform | $4 | $3.76 | $3.84 | +2.1% | +0.5% | -2.6% | -2.4% | +1.7% | +3.3% |
| Aug 8 | Maxim Group | Maintains | Buy → Buy | — | $2.89 | $3.40 | +17.6% | +34.9% | +15.1% | -5.1% | -3.3% | -2.9% |
| Nov 12 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $1.61 | $1.65 | +2.5% | +1.9% | -0.6% | -3.1% | -1.3% | +1.9% |
| May 15 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $2.13 | $2.20 | +3.3% | -3.8% | +10.7% | +4.0% | -3.0% | -0.4% |
| Mar 8 | Benchmark | Upgrade | Hold → Speculative Buy | — | $3.02 | $2.93 | -3.0% | -10.6% | -9.6% | -4.9% | -2.6% | -4.4% |
| Jan 26 | B. Riley FBR | Maintains | Buy → Buy | — | $7.91 | $8.10 | +2.4% | +8.1% | -2.8% | +1.4% | -4.5% | -5.5% |
| Jan 26 | B. Riley Securities | Maintains | Buy → Buy | — | $7.91 | $8.10 | +2.4% | +8.1% | -2.8% | +1.4% | -4.5% | -5.5% |
| Nov 25 | Benchmark | Maintains | Speculative Buy → Buy | — | $5.94 | $6.00 | +1.0% | +4.2% | -2.1% | +3.0% | +3.0% | -3.7% |
| Nov 25 | Maxim Group | Maintains | Buy → Buy | — | $5.94 | $6.00 | +1.0% | +4.2% | -2.1% | +3.0% | +3.0% | -3.7% |
| Oct 24 | Benchmark | Maintains | Speculative Buy → Buy | — | $9.61 | $10.04 | +4.5% | -1.1% | -4.6% | +5.6% | +0.6% | -6.4% |
| Oct 4 | Maxim Group | Maintains | Buy → Buy | — | $8.75 | $8.75 | +0.0% | +5.1% | +8.7% | -5.5% | -4.0% | -1.9% |
No insider trades available.
8-K · 7.01
! Medium
Nephros, Inc. -- 8-K 7.01: Regulation FD Disclosure
Nephros furnished a presentation as a regulatory disclosure, though the specific content details weren't provided in this filing summary.
Jun 15
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
I cannot provide a meaningful analysis because the filing content is incomplete and corrupted—the actual disclosure details are missing, making it impossible to assess financial impact or investment implications for NEPH.
Mar 27
Institutional (13F) — Top 14
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Wexford Capital Lp | 3,600,552 | $11M | — | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 198,643 | $592K | New | Mar 2026 |
| 3 | Renaissance Technologies Llc | 99,400 | $296K | Reduced | Mar 2026 |
| 4 | Hightower Advisors, Llc | 59,710 | $291K | Added | Dec 2025 |
| 5 | Morgan Stanley | 35,918 | $175K | Added | Dec 2025 |
| 6 | Essex Investment Management Co Llc | 38,984 | $116K | — | Mar 2026 |
| 7 | Blair William & Co/il | 36,249 | $108K | — | Mar 2026 |
| 8 | De Lisle Partners Llp | 25,000 | $74K | — | Mar 2026 |
| 9 | Cannell & Spears Llc | 22,000 | $66K | — | Mar 2026 |
| 10 | Citadel Advisors Llc | 20,888 | $62K | Added | Mar 2026 |
| 11 | Prelude Capital Management, Llc | 13,680 | $41K | Reduced | Mar 2026 |
| 12 | Elkhorn Partners Limited Partnership | 12,000 | $36K | Added | Mar 2026 |
| 13 | Northern Trust Corp | 10,828 | $32K | — | Mar 2026 |
| 14 | Royal Bank Of Canada | 747 | $2K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 10
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 30,695 | $120K | Feb 2026 |
| 2 | Fidelity Total Market Index Fund | 11,571 | $42K | May 2026 |
| 3 | Fidelity Series Total Market Index Fund | 9,528 | $35K | May 2026 |
| 4 | U.S. Sustainability Core 1 Portfolio | 3,337 | $14K | Jan 2026 |
| 5 | Fidelity Nasdaq Composite Index Fund | 3,085 | $12K | Feb 2026 |
| 6 | U.S. CORE EQUITY 2 PORTFOLIO | 2,725 | $12K | Jan 2026 |
| 7 | Dimensional US Core Equity 1 ETF | 2,462 | $11K | Jan 2026 |
| 8 | U.S. CORE EQUITY 1 PORTFOLIO | 2,333 | $10K | Jan 2026 |
| 9 | U.S. Social Core Equity 2 Portfolio | 2,332 | $10K | Jan 2026 |
| 10 | Dimensional US Sustainability Core 1 ETF | 409 | $2K | Jan 2026 |
Valuation
Market Cap
$48.0M
Enterprise Value
$42.6M
P/E (TTM)
62.04x
Forward P/E
73.00x
PEG Ratio
0.03x
P/B
4.56x
P/S
2.51x
P/FCF
29.20x
EV/EBITDA
49.76x
Shares Out
11.0M
Financials (TTM)
Revenue
$19.1M
Net Income
$776K
EBITDA
$857K
Free Cash Flow
$1.6M
Op Cash Flow
$1.6M
EPS Basic
$0.11
EPS Diluted
$0.07
EPS Forward
$0.06
Gross Margin
59.1%
Op Margin
3.5%
Net Margin
4.1%
Balance Sheet
Total Assets
$13.6M
Total Liab.
$3.4M
Total Equity
$10.2M
Cash
$5.4M
LT Debt
$0
Book Value/Sh
$0.96
Debt/Equity
0.10x
Current Ratio
4.06
Quick Ratio
2.89
Returns & Growth
ROE
14.3%
ROA
8.8%
ROIC
10.1%
Rev Growth YoY
+32.7%
EPS Growth YoY
+1471.4%
Price Returns
2W
+15.7%
1M
+27.2%
3M
+19.6%
6M
+8.8%
12M
+7.9%
Technicals
52W High
$5.79
52W Low
$2.78
50d MA
$3.51
200d MA
$3.98
RSI (14)
67.70
ATR (14)
$0.30
Beta
1.56
Avg Volume
14K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 2:42pm
· Source: financialmodelingprep.com